PPARγ

PPARγ (Peroxisome Proliferator-Activated Receptor Gamma) is a ligand-activated nuclear receptor that functions as a central transcriptional regulator of adipocyte differentiation, lipid metabolism, insulin sensitivity, inflammation, and cellular energy homeostasis^[1][2]. Mechanistically, PPARγ forms heterodimers with retinoid X receptors and regulates target gene expression through PPAR response elements, thereby coordinating metabolic and transcriptional programs that govern adipose tissue development and systemic glucose and lipid metabolism^[3][4]. Because of its pivotal role in adipogenesis and insulin-responsive pathways, PPARγ has been extensively implicated in obesity, type 2 diabetes, metabolic syndrome, and related metabolic disorders^[1][3]. In addition to metabolic regulation, PPARγ contributes to immune-cell maturation and function, particularly in macrophages and other inflammatory cell populations, linking metabolic signaling with inflammatory responses^[4]. Compared with the related PPARα and PPARδ isoforms, which are predominantly associated with fatty acid oxidation and broader energy utilization pathways, PPARγ is distinguished by its dominant role in adipocyte differentiation and adipose tissue function^[3]. Furthermore, alternative promoter usage and splicing generate multiple PPARG transcript variants, including γ1, γ2, and γ3, with evidence indicating isoform-specific regulation and distinct metabolic functions in different tissues^[2][5]. For experimental applications, synthetic thiazolidinedione agonists activate PPARγ and improve insulin sensitivity, making them valuable pharmacological tools for investigating metabolic regulation, although their clinical use is limited by adverse effects such as weight gain^[3][5].